India's New FTAs to Open Major Opportunities for Pharma, Healthcare Industry: Piyush Goyal

Maret 15, 2026 - 02:50
 0  0
India's New FTAs to Open Major Opportunities for Pharma, Healthcare Industry: Piyush Goyal

New Delhi: The nine free trade agreements (FTAs) finalised by India in the last four years will provide huge business opportunities for the domestic pharma and healthcare sectors, Commerce and Industry Minister Piyush Goyal said on Monday.

India has finalised FTAs with the UK, Mauritius, Australia, the US, European Union, the four-nation bloc EFTA, Oman, the UAE and New Zealand.

While the pacts with Mauritius, Australia, the UAE and EFTA are implemented, the remaining agreements are likely to come into force soon.

"These agreements open new opportunities for pharmaceuticals, healthcare and medtech sectors," Goyal said in a post-Budget webinar. He suggested the industry to focus on taking greater advantage of these pacts and developing a strong healthcare ecosystem.

"We need to develop a comprehensive, holistic and integrated healthcare system," he said.

The minister informed that FTA negotiations with the Gulf Cooperation Council and Eurasia are progressing well. Speaking at a separate function on intellectual property, Goyal said the ministry is taking steps to fast-track approvals of IP applications.

He informed that patent filing in the country has increased 215 per cent over the last one decade."Our idea is that the IP approval process, whether it's trademark or patent or copyright, or design or GI...we should be at least amongst the top 5 in the world," the minister said.

Apa Reaksi Anda?

Suka Suka 0
Kurang Suka Kurang Suka 0
Setuju Setuju 0
Tidak Setuju Tidak Setuju 0
Bagus  Bagus 0
Berguna Berguna 0
Hebat Hebat 0
Edusehat Platform Edukasi Online Untuk Komunitas Kesehatan Agar Mendapatkan Informasi Dan Pengetahuan Terbaru Tentang Kesehatan Dari Nasional Maupun Internasional. || An online education platform for the health community to obtain the latest information and knowledge about health from both national and international sources.